News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
Proyecto FRACTAL
Natac Biotech receives €1.4 Million from the Spanish Ministry of Industry for the FRACTAL Project
Financing
The funding will support the development of a new generation of high-value natural ingredients…
Partners - Natac Group
Oryzon
ORYZON announces U.S. patent grant for vafidemstat in borderline personality disorder (BPD)
Healthcare · Rare diseases · Innovative drugs
Granted claims cover the use of vafidemstat for treating non-aggressive symptoms of BPD.
Partners - Oryzon Genomics
oryzon
ORYZON raises €12 million and signs a financing agreement with COFIDES to strengthen its balance sheet and accelerate its clinical programs
Healthcare · Innovative drugs · Financing
Priced at €2.70 per share, representing a 14.15% discount on the five day VWAP and a 12.68%…
Partners - Oryzon Genomics
Laboratorio de seguridad química
Biobide's DNT assay validated by NIH and US-EPA
Healthcare · Drug discovery · International
A study led by NIEHS/NIH, with participation from Biobide, the US-EPA, the University of Konstanz,…
Partners - Biotechnology Assets
Antonio Delgado, CEO de Natac
Natac participates in The Sustainable Wellness Summit in London
Industrial biotechnology · Bioeconomy · Circular economy
The company strengthens its international positioning as a leading provider of sustainable…
Partners - Natac Group
La tecnología HyperSperm de Fecundis aumenta la cantidad y la calidad de los embriones obtenidos mediante fecundación in vitro
Fecundis HyperSperm technology increases the number and quality of embryos produced through in vitro fertilisation
Healthcare · Access to innovation · International
A new clinical trial shows that HyperSperm technology, developed by the biotech start-up Fecundis,…
Partners - Parc Científic de Barcelona
Logo Theriva Biologics
Theriva™ Biologics Announces Results from VCN-01 Phase 1 Clinical Trial in Head and Neck Cancer Published in Clinical Cancer Research
Healthcare · Access to innovation · Innovative drugs
Prolonged overall survival (OS) was observed in heavily pre-treated refractory Head & Neck…
Partners - THERIVA BIOLOGICS S.L.
GENESIS Biomed lidera el European PHEMS Business Hackathon en Barcelona para dar forma al futuro del Espacio de Datos de Salud Pediátrica
GENESIS Biomed leads the European PHEMS Business Hackathon in Barcelona to shape the future of the Paediatric Health Data Space
EU projects · Digitalization
More than 50 stakeholders gathered in Barcelona in an international Hackathon organized and…
Partners - GENESIS Biomed
BCN HEALTH presenta en Sevilla un estudio sobre la carga económica de la insuficiencia cardíaca en Europa en el marco del proyecto STRATIFYHF
BCN HEALTH presents in Seville a study on the economic burden of heart failure in Europe within the STRATIFYHF project
Healthcare · Access to innovation · EU projects
Partners - BCN Health